Skip to main content

Zhou Rong's Form 4 filing

Amphastar Pharmaceuticals, Inc. (AMPH) · filed Dec 5, 2023

Accession no.
0001104659-23-123689
Filed
Dec 5, 2023
Trade date
Dec 1-4, 2023
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $462.2K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Zhou RongCIK 0001645326Officer (Senior EVP, Production Center)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 1, 2023Common StockMOption exerciseAcquired+4,316$14.40+$62,150.4116,736Direct
Dec 1, 2023Common StockSSaleDisposed−4,316$58.58−$252,831.28112,420Direct
Dec 4, 2023Common StockMOption exerciseAcquired+3,514$16.19+$56,891.66115,934Direct
Dec 4, 2023Common StockSSaleDisposed−3,514$59.58−$209,364.12112,420Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 1, 2023Common StockMOption exerciseDisposed−4,316$0.00$00Direct
Dec 4, 2023Common StockMOption exerciseDisposed−3,514$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)